Actively Recruiting
Coronary Artery Disease and Coronary Microvascular Disease in Cardiomyopathies Registry
Led by University Hospital, Grenoble · Updated on 2022-05-19
1600
Participants Needed
1
Research Sites
520 weeks
Total Duration
On this page
Sponsors
U
University Hospital, Grenoble
Lead Sponsor
C
Clinique Belledonne
Collaborating Sponsor
AI-Summary
What this Trial Is About
Long-term prognostic value of macrovascular and microvascular coronary artery stenoses in each type of cardiomyopathy.
CONDITIONS
Official Title
Coronary Artery Disease and Coronary Microvascular Disease in Cardiomyopathies Registry
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Diagnosis of ischemic cardiomyopathy
- Diagnosis of dilated cardiomyopathy
- Diagnosis of hypertrophic cardiomyopathy
- Diagnosis of restrictive cardiomyopathy
You will not qualify if you...
- Pregnant women
- Breastfeeding women
- Patients under legal protection
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
University Hospital Grenoble
La Tronche, France, 38700
Actively Recruiting
Research Team
C
Clémence CHARLON
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here